Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scandinavian ChemoTech's co-founder Göran Hellers has passed away

It is with great sadness that we announce that the Company's co-founder, former board member and our friend, Göran Hellers, has died after a short illness.“With great sadness in my heart, I have today received information that my friend and co-founder of ChemoTech has passed away. Since we met 10 years ago, Dr Göran has been an extremely knowledgeable and driven colleague who, alongside me, launched the first generation of electroporation in Asia, Africa and South America. It was during those years that Göran and I saw the shortcomings of the older electroporation method and realized that

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:03 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Ville Raitio Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10372/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:02 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Tiina Kuusisto Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10369/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:01 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Irene Kantor Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10366/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details (1):

BEWI ASA – Approval of prospectus for listing of shares in connection with acquisition of Jackon

Reference is made to the stock exchange announcement published by BEWI ASA ("BEWI" or the "Company") on 1 October 2021 regarding its offer to acquire all shares in Jackon Holding AS ("Jackon") and the announcement published on 15 October 2021 where it was announced that HAAS AS, an owner of 50 per cent of the shares in Jackon, had accepted the offer and chosen to receive its consideration in the form of 32,070,000 new shares in BEWI (the "Consideration Shares"). Reference is further made to the extraordinary general meeting held on 16 February 2022, where the Company's shareholders resolved

Kojamo Plc: Managers` Transactions

Kojamo Plc Stock Exchange Release, 21 February 2022 at 3:00 p.m. EETKojamo Oyj - Managers' Transactions Person subject to the notification requirement Name: Katri Harra-Salonen Position: Other senior manager Issuer: Kojamo Oyj LEI: 7437007YPUOQZ8OV1R42 Notification type: INITIAL NOTIFICATION Reference number: 10365/5/4 ____________________________________________ Transaction date: 2022-02-17 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000312251 Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details

CapMan’s Annual Report for 2021 published

CapMan Plc Stock Exchange Release / Annual Financial Report21 February 2022 at 15:00 EET CapMan’s Annual Report for 2021 published CapMan has published its Annual Report for 2021 on its website at www.capman.com/annual-reports/. The report includes the Report of the Board of Directors, the Group Financial Statements, the Auditor’s Report and the Corporate Governance Statement. CapMan also publishes the Annual Report in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (xHTML).

Fiskars’ Annual Report 2021 published

Fiskars CorporationStock Exchange ReleaseFebruary 21, 2022 at 15.00 (EET) Fiskars’ Annual Report 2021 published Fiskars Corporation has today published its Annual Report for the year 2021. The Annual Report 2021 consists of the Board of Director’s report, the Financial Statements and the Auditor’s report, the Corporate Governance Statement, the Remuneration Statement and the Sustainability report. All of the above statements are attached to this release and are also available on Fiskars’ website at https://fiskarsgroup.com/investors/reports-and-presentations/annual-and-interim-

Healthcare heavyweight joins Cardo Health on its mission to improve the health of millions of people in emerging markets as co-founder and deputy CEO

Masha Feigelman is joining Cardo Health as co-founder and deputy CEO. She is a former partner at McKinsey (20+ years) where she built and scaled the European start-up and healthcare practises including setting up Russia's McKinsey healthcare practice.  Throughout her career Masha has supported organisational transformation and built new business, including service lines for McKinsey. Since leaving McKinsey in 2020 Masha has advised and coached multiple digital health start-ups and scaleups on strategic and organisational topics - from international expansion to OKR implementation. Masha is

Aptahem reports additional positive biological effect in a Corona virus-induced acute lung injury model treated with Apta-1

Aptahem can today announce that in addition to previously reported positive preliminary data, the Toronto team has, from further studies, found essential positive effects in a Corona virus challenge induced Acute Lung Injury model with Apta-1 treatment. Studies show that Apta-1 preliminary protects and recovers the lung tissue, significantly reduce the virus count and hemolysis, plus improves the clinical markers for the liver and kidneys. Previous studies show that Apta-1 supports and maintains systemic circulation, which is crucial to keeping the organism vital.Research commissioned by

Terrafame Ltd publishes its full year 2021 result on 4 March 2022

MEDIA RELEASE Terrafame Ltd publishes its full year 2021 result on Friday 4 March 2022 approximately at 09.00 a.m. Finnish time (please note the changed date). The report will be available on the company’s website at www.terrafame.com after publishing. Webcast briefing in Finnish for media representatives will be held on the same day at 01:00 p.m. Finnish time. In the briefing the result will be presented by Terrafame Ltd’s CEO Joni Lukkaroinen and Chief Financial Officer Ville Sirviö. The webcast can be viewed at terrafame.videosync.fi/tammi-joulukuu-2021. Questions can be asked by

Correction: DAMPSKIBSSELSKABET NORDEN A/S – WEEKLY REPORT ON SHARE BUY-BACK

ANNOUNCEMENT NO. 46 - 21 FEBRUARY 2022 On 4 November 2021, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 4 November 2021 up to and including no later than end February 2022. For details, please see announcement no. 75 of 4 November 2021. Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 40 million (approximately DKK 263 million).

The scientific article "Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging" is now published in the scientific journal Nature Protocols

The scientific article entitled "Bioconjugation of photon-upconversion nanoparticles for cancer biomarker detection and imaging" is now published in the scientific journal Nature Protocols. Read the article here.    Dr. Matthias Mickert, Senior Chemical Engineer at Lumito, was part of the Gorris group at the University of Regensburg, which

Correction: Transfer of Own Shares as Remuneration

CHANGES IN COMPANY’S OWN SHARES FEBRUARY 21, 2022 AT 14.15 Wulff Group Plc corrects March 21 at 11.00 a.m. published release as follows: · Following the transfer, the company holds 44,812 of its own shares. The corrected release is below. The Board of Directors decided to issue 10,000 of the company’s own shares to CEO Pienimäki as remuneration for 2021 based on the short-term incentive scheme that was established on 22 February 2021. The transfer of the shares is based on the authorisation given to the Board of Directors by the Annual General Meeting on 8 April 2021.

Webstep ASA: Long-Term Incentive Program grant of share options to primary insider

Oslo, 21 February 2022: On 21. February 2022, primary insider Erlend Nævdal, Director of Business Development in Webstep ASA (the “Company”), was granted 25,000 share options in the Company under the Company's LTIP-program, which was approved by the annual general meeting on 8 May 2019.The grant of share options is decided  to be on equal terms as the grant of share options in November 2021, Erlend Nævdal was at that time departmentleader in Bergen Solutions. The strike price of the allocated share options is NOK 36.6 per share option, equal to the volume weighted average share price for

Pediatric diabetes study with ProTrans in progress

NextCell Pharma AB ("NextCell") has previously announced a clinical trial with ProTrans™ to treat children and adolescents with type 1 diabetes. The study recently started with screening of patients. Before treatment, patients are followed for about a month and the first adolescents will soon undergo treatment.The first part of the study is a safety part (phase Ib) where all patients are treated at Akademiska university hospital. 3 patients aged 12-18 years receive treatment first and there after 3 patients aged 7-11 years. The data will then be reviewed by the Data Safety Monitoring Board,

Hexagon announces strategic partnership with H2U to digitalise green hydrogen plant construction

Hexagon AB, a global leader in digital reality solutions combining sensor, software and autonomous technologies, today announced a strategic partnership agreement with The Hydrogen Utility Pty Ltd (H2U), a leading Australian hydrogen infrastructure developer, to deliver best-in-class digital asset management solutions in support of the global green hydrogen revolution. The partnership brings together Hexagon’s deep expertise in integrating industrial facility digital ecosystems with H2U’s green hydrogen and green ammonia proprietary plant designs.The ability to create engineering and

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 14 February 2022 – 18 February 2022, acquired a total of 377,000 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value. The repurchase program, announced 3 December 2021, is thereby completed and closed.The repurchase programme, which Evolution announced on 3 December 2021, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission

Mekonomen Group is increasing its focus on efficiency through a new high-tech central warehouse

Mekonomen Group strengthens its focus on increased efficiency and availability for customers. The Group's Danish business area FTZ will build a new high-tech automated central warehouse with head office and training academy outside Odense. The initiative aims to further strengthen competitiveness and strengthen Mekonomen Group's already leading position in Denmark. The new facility will be completed in 2024. FTZ is Denmark's leading supplier of spare parts in the vehicle aftermarket and now plans to gather central warehouse, regional warehouse, administration and training academy in a

Observe Medical ASA: New order for Sippi systems received from Poland

Oslo, February 21, 2022 - Observe Medical ASA (OSE: OBSRV) today announces a new order for Sippi systems, from our distributor in Poland, Skamex.    Observe Medical ASA (the "Company") has today, on 21 February 2022, received an order for  30 Sippi® Base units and 300 Sippi® Disposable units from Skamex. The total order value for the Company is approximately EURO 10,000 as these products will be delivered based on the initial launch period pricing agreed with Skamex, valid until the end of the first quarter 2022. Expected delivery of the order is late Q1 or early Q2 2022. The Company

Swedish Kiliaro sees great growth potential in the integrity trend

The fact that the number of users on Facebook is declining may be due to the fact that today's users on social media care more about privacy. The founders behind the photo app Kiliaro believe that the trend is here to stay as more young users choose private photo sharing.The first days of February were turbulent for the social media giant Facebook, this after the Meta share dropped by 25 percent as the number of users on the platform decreased. Analysts from the international finance company UBS have since tried to understand the underlying mechanisms and believe that there has been a shift

Welcome to SEB’s Annual General Meeting on 22 March 2022

Skandinaviska Enskilda Banken AB (”SEB”) will hold its Annual General Meeting (AGM) on Tuesday 22 March 2022, at 13:00 CET at Stockholm Concert Hall, Hötorget, Stockholm. Given the continued spread of Covid-19, the Board of Directors has decided that shareholders shall be able to exercise their voting rights at the AGM also by postal voting in accordance with the regulations in SEB's Articles of Association. It will also be possible to follow the meeting online, via sebgroup.com , but without the opportunity to vote or ask questions. In addition to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top